loading exam hub…
loading exam hub…
Full JRCPTB Respiratory Medicine curriculum coverage, BTS, ERS and GOLD guidance, candidate-reported pitfalls and an AI-adaptive question bank by UK chest physicians — grounded in asthma biologics, COPD optimisation, ILD pathways, lung cancer staging and sleep medicine.
100 best-of-five SBAs · 3 hours · computer-based at Pearson VUE designated test centres
100 best-of-five SBAs · 3 hours · same day, after a 1-hour break · imaging, PFTs, sleep traces
Pitched at the level of a doctor approaching CCT in respiratory medicine — imaging interpretation, biologic eligibility, ILD multidisciplinary workup
2026/01 sitting: 2 September 2026. Application window: 13 May–10 June 2026. Reasonable adjustment deadline: 18 June 2026. Results released approximately 6 weeks after the exam. From June 2026 sittings are delivered in centre.
Approximate question distribution across the JRCPTB Respiratory Medicine curriculum. Used to drive iatroX adaptive sequencing.
Source: official Federation of the Royal Colleges of Physicians of the UK blueprint
Drawn from the JRCPTB curriculum, BTS/GOLD/ERS guidelines and item density in iatroX.
COPD GOLD 2024/25 — Group A/B/E classification, LAMA-LABA-ICS triple therapy criteria (eosinophil-guided), exacerbation management with corticosteroids/antibiotics, NIV for hypercapnic respiratory failure
Asthma biologics per BTS/NICE — omalizumab (anti-IgE), mepolizumab/reslizumab/benralizumab (anti-IL-5/5R), dupilumab (anti-IL-4Rα), tezepelumab (anti-TSLP). Eligibility thresholds (eosinophils, FeNO, IgE level)
Lung cancer — TNM 9th edition (2024 update), reflex driver mutation testing (EGFR/ALK/ROS1/BRAF/RET/MET/KRAS/HER2), neoadjuvant chemo-IO (CheckMate 816), adjuvant osimertinib (ADAURA), small-cell limited and extensive disease IO + chemo
IPF and progressive pulmonary fibrosis — antifibrotic eligibility (FVC thresholds), CT-HRCT pattern recognition (UIP, NSIP, OP), CTD-ILD screening (anti-MDA5 in dermatomyositis, anti-Scl-70 in SSc), recent CHEST/ATS PPF guidance
Pulmonary embolism — ESC 2024 guidelines, intermediate-low vs intermediate-high vs high-risk PE, thrombolysis criteria, DOACs first-line for most, BTS PE outpatient management
OSA — STOP-BANG, AHI thresholds for CPAP, central vs obstructive apnoea, complex sleep apnoea on initiation. Hypoventilation syndromes (OHS, motor neurone disease, neuromuscular)
CFTR modulators — elexacaftor-tezacaftor-ivacaftor (ETI/Trikafta/Kaftrio), age and mutation eligibility, monitoring (LFTs, mental health), implications for transplant listing
Pleural disease BTS 2023 update — pneumothorax conservative management, malignant pleural effusion (IPC vs talc), septated empyema (intra-pleural tPA-DNase per MIST-2), mesothelioma staging
Observations from UK respiratory trainees and recent SCE candidates. Verify against current BTS, NICE and GOLD guidance.
Candidate-reported observations — not official guidance.
A pragmatic phased approach used by recent ST5–ST6 respiratory medicine passers.
A live item from the iatroX bank. Try it before launching a full session.
A sample SCE Respiratory Medicine question will appear here shortly. In the meantime, launch a free practice session.
try a free question →Why iatroX is built differently for SCE Respiratory Medicine.
Every iatroX item is tagged to a blueprint topic, so your performance dashboard mirrors the structure of the exam itself.
The engine surfaces your weakest topics first, in real time, instead of marching you through a static syllabus.
Incorrect items return at increasing intervals to interrupt the forgetting curve and lock knowledge into long-term memory.
Timed full-length simulations that mirror the official exam structure under realistic conditions.
One iatroX subscription includes the SCE Respiratory Medicine bank plus every other premium iatroX exam bank.
Cancel anytime · 30-day money-back guarantee on annual
Over 1,000 best-of-five SBAs mapped to the JRCPTB Respiratory Medicine curriculum and Federation blueprint. Items are reviewed regularly against current BTS, NICE, GOLD and ERS guidance with substantial image-led HRCT and PFT content.
Once yearly in September. The 2026 sitting is on 2 September 2026. Applications open 13 May 2026 and close 10 June 2026. Results are released approximately 6 weeks after the exam.
Two papers of 100 best-of-five SBAs each, three hours per paper, sat on the same day with a one-hour break between. Total 200 questions. From June 2026 all sittings are in-centre at Pearson VUE locations. Paper 2 is widely reported to carry more image and PFT-style items.
Most UK trainees sit during ST5 or ST6 (penultimate year of higher specialty training). There are no formal restrictions on when in training you sit, but CCT requires a pass before completion. International candidates can sit at any time once registered with the Federation.
UK fee is £700; international fee is £875. Fees are non-refundable after the application closing date. From June 2026 all sittings are delivered in-centre at Pearson VUE locations.
Substantial. Paper 2 carries more imaging (HRCT, plain chest film, CT-PA), PFT traces, sleep studies and bronchoscopy findings. Dedicated image practice is essential — iatroX includes a respiratory image bank covering UIP/NSIP/OP HRCT patterns, PFTs and CT lung cancer staging.
Yes. A single iatroX subscription (£29/month or £99/year for UK users; $29/$99 elsewhere) includes the SCE Respiratory Medicine bank alongside every other premium iatroX exam bank. No add-ons or per-exam fees.
Other iatroX hubs you may find useful.
see how iatroX compares to PassMedicine, Quesmed, NICE CKS, BNF.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP · Last reviewed 12 May 2026
See our methodology and editorial policy.